Grimaldi et al. recently demonstrated that a decreased TAPSE/sPAP ratio predicts adverse outcomes and is associated with elevated natriuretic peptide levels (TAPSE/sPAP ratio and NT-proANP in SSc) in SSc patients with cardiovascular involvement (19). Here, PDZK1IP1 is linked to systemic sclerosis.